ProfileGDS4718 / 1561566_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 5% 6% 7% 8% 3% 13% 7% 16% 7% 8% 7% 4% 8% 12% 6% 6% 11% 6% 9% 2% 12% 6% 7% 6% 6% 7% 7% 2% 4% 4% 4% 14% 5% 6% 7% 7% 6% 7% 9% 10% 9% 10% 6% 10% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.584725
GSM549102patient 115, normal, homogenized [OPG study]3.638076
GSM549104patient 119, normal, homogenized [OPG study]3.630497
GSM549108patient 138, normal, homogenized [OPG study]3.721248
GSM549119patient 077, normal, homogenized [OPG study]3.506693
GSM549133patient 032, cancer, homogenized [OPG study]3.8314413
GSM549139patient 042, cancer, homogenized [OPG study]3.657527
GSM549099patient 107, normal, homogenized [OPG study]4.0062616
GSM549109patient 139, normal, homogenized [OPG study]3.702337
GSM549110patient 046, normal, homogenized [OPG study]3.701968
GSM549114patient 063, normal, homogenized [OPG study]3.649517
GSM549122patient 082, normal, homogenized [OPG study]3.57014
GSM549134patient 033, cancer, homogenized [OPG study]3.683558
GSM549136patient 036, cancer, homogenized [OPG study]3.8058712
GSM549140patient 044, cancer, homogenized [OPG study]3.589946
GSM549111patient 047, normal, homogenized [OPG study]3.621796
GSM549113patient 057, normal, homogenized [OPG study]3.7957811
GSM549132patient 031, cancer, homogenized [OPG study]3.633176
GSM549137patient 038, cancer, homogenized [OPG study]3.749179
GSM549142patient 047, cancer, homogenized [OPG study]3.473122
GSM549100patient 110, normal, homogenized [OPG study]3.8634812
GSM549107patient 135, normal, homogenized [OPG study]3.612296
GSM549115patient 068, normal, homogenized [OPG study]3.651417
GSM549116patient 072, normal, homogenized [OPG study]3.629796
GSM549120patient 078, normal, homogenized [OPG study]3.618016
GSM549131patient 030, cancer, homogenized [OPG study]3.642997
GSM549118patient 074, normal, homogenized [OPG study]3.692377
GSM549129patient 027, cancer, homogenized [OPG study]3.468342
GSM549123patient 088, normal, homogenized [OPG study]3.55324
GSM549124patient 006, cancer, homogenized [OPG study]3.563434
GSM549126patient 015, cancer, homogenized [OPG study]3.516244
GSM549128patient 025, cancer, homogenized [OPG study]3.8896214
GSM549103patient 117, normal, homogenized [OPG study]3.585415
GSM549117patient 073, normal, homogenized [OPG study]3.646156
GSM549138patient 041, cancer, homogenized [OPG study]3.642597
GSM549141patient 045, cancer, homogenized [OPG study]3.619467
GSM549130patient 028, cancer, homogenized [OPG study]3.63646
GSM549101patient 111, normal, homogenized [OPG study]3.670237
GSM549105patient 128, normal, homogenized [OPG study]3.739419
GSM549106patient 134, normal, homogenized [OPG study]3.7315710
GSM549112patient 048, normal, homogenized [OPG study]3.731289
GSM549125patient 011, cancer, homogenized [OPG study]3.7962210
GSM549127patient 024, cancer, homogenized [OPG study]3.606746
GSM549135patient 035, cancer, homogenized [OPG study]3.719910